SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 91 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,841 | -60.5% | 28,257 | -47.0% | 0.00% | – |
| Q2 2023 | $133,728 | +1361.3% | 53,278 | +918.9% | 0.00% | – |
| Q1 2023 | $9,151 | -62.3% | 5,229 | -8.4% | 0.00% | – |
| Q4 2022 | $24,251 | -3.0% | 5,706 | -73.0% | 0.00% | – |
| Q3 2022 | $25,000 | +19.0% | 21,100 | +1.0% | 0.00% | – |
| Q2 2022 | $21,000 | -80.4% | 20,900 | -52.0% | 0.00% | – |
| Q1 2022 | $107,000 | -52.9% | 43,586 | -48.4% | 0.00% | – |
| Q4 2021 | $227,000 | -74.4% | 84,486 | -52.3% | 0.00% | – |
| Q3 2021 | $886,000 | +123.2% | 177,060 | +233.0% | 0.00% | – |
| Q2 2021 | $397,000 | +31.5% | 53,165 | +3.4% | 0.00% | – |
| Q1 2021 | $302,000 | +42.5% | 51,400 | +14.2% | 0.00% | – |
| Q4 2020 | $212,000 | +76.7% | 45,000 | +28.6% | 0.00% | – |
| Q3 2020 | $120,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |